Dummy Vapes, the e-cigarette brand, has recently filed a lawsuit against its brand partner and rapper 6ix9ine, following reports by TMZ on September 20th. The lawsuit was prompted by dissatisfaction over the alleged poaching of 6ix9ine by their competitor, Fume.
According to the lawsuit documents, Dummy Vapes had previously signed an exclusive endorsement contract with 6ix9ine in February 2023. However, in June, the company learned that Fume had offered 1 million dollars to 6ix9ine in hopes of collaborating with him. However, this proposal evidently failed, leading Fume to turn to 6ix9ine's girlfriend, Yailin la Mas Viral, and sign a contract worth 250,000 dollars with her.
Afterwards, Fume launched 14 different e-cigarette flavors, some of which were named "Dummy Vapes by Fume". Dummy Vapes has confirmed that 6ix9ine indeed released a public service advertisement where he explicitly claimed to be a member of Dummy Vapes and stated that he only engaged in business communication with Fume through his girlfriend's contract.
However, when Dummy Vapes paid $60,000 for 6ix9ine's private plane travel, preparing him to promote the brand at an industry event in Las Vegas, they were forced to withdraw due to Fume's demands. Now, Dummy Vapes is seeking unspecified damages in a lawsuit.
In the previous two interviews with Fume, its staff claimed that Fume is the largest e-cigarette brand in Florida, USA.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
